Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GPR40 agonists in anti-diabetic drug combinations

GPR40 agonists in anti-diabetic drug combinations

US Patent 10195178 · Granted Feb 5, 2019

Estimated economic value: $80,901,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy for the treatment of diabetes2023
System for early warning and positioning of overheating inside lithium ion batte2021
Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators2020
Inflatable curtain and method for placing an inflatable curtain in a stored cond2017
Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the incr2014
Combination therapy comprising glucose reabsorption inhibitors and PPAR modulato2012
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs2012
Combination therapy comprising glucose reabsorption inhibitors and retinoid-X re2012
Methods of using alpha-methylglucoside (AMG) as an indicator for glucose absorpt2012
Methods of using alpha-methylglucoside (AMG) as an indicator for glucose absorpt2012
3,4-dihydro-2H-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors2011
1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors2011